Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$0.35 - $0.53 $240 - $364
687 New
687 $1.35 Million
Q4 2021

Jan 21, 2022

SELL
$4.99 - $7.46 $53,577 - $80,098
-10,737 Closed
0 $0
Q2 2021

Jul 14, 2021

SELL
$6.23 - $10.03 $83,027 - $133,669
-13,327 Reduced 55.38%
10,737 $100,000
Q1 2021

Apr 19, 2021

BUY
$8.81 - $16.96 $116,353 - $223,990
13,207 Added 121.65%
24,064 $219,000
Q4 2020

Jan 22, 2021

BUY
$8.5 - $12.85 $92,284 - $139,512
10,857 New
10,857 $96.1 Million
Q3 2020

Oct 21, 2020

SELL
$9.57 - $27.05 $114,505 - $323,653
-11,965 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$7.14 - $31.69 $12,602 - $55,932
1,765 Added 17.3%
11,965 $322,000
Q1 2020

Jul 20, 2020

BUY
$2.98 - $14.09 $30,396 - $143,718
10,200 New
10,200 $76,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $494M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.